Browse > Article
http://dx.doi.org/10.48022/mbl.2111.11008

Production of α-Glucosidase Inhibitor and 1-Deoxynojirimycin by Bacillus subtilis MORI  

Park, Young Shik (Department of Biotechnology and Biomarketing, The University of Suwon)
Lee, Jae Yeon (Department of Biotechnology and Biomarketing, The University of Suwon)
Hwang, Kyo Yeol (Department of Biotechnology and Biomarketing, The University of Suwon)
Kim, Keun (Department of Biotechnology and Biomarketing, The University of Suwon)
Publication Information
Microbiology and Biotechnology Letters / v.49, no.4, 2021 , pp. 566-575 More about this Journal
Abstract
Galactose and soybean meal were selected as the best carbon and nitrogen sources, repectively, for the efficient production of α-glucosidase inhibitor (AGI) and 1-deoxynojirimycin (DNJ) by a newly isolated Bacillus subtilis MORI. The optimal concentrations of the galactose and soybean meal for the production of AGI and DNJ were investigated by response surface methodology. For the production of AGI, the optimal galactose and soybean meal concentrations were 4.3% (w/v) and 3.2% (w/v), respectively, and for DNJ, 4.5% (w/v) and 3.0% (w/v), respectively. The nearly identical optimal concentrations of galactose and soybean meal for the production of both AGI and DNJ indicated a close correlation between the production of AGI and DNJ. The maximum production of AGI (50,880 GIU/ml) and DNJ (824 ㎍/ml) obtained from the statistically optimized medium in a jar fermenter was 2.33 and 2.38-fold, respectively, higher than those (21,798 GIU/ml and 346 ㎍/ml, respectively) of the pre-optimized medium. The production of both AGI and DNJ was greatly increased by jar fermentation (AGI of 38,524 GIU/ml and DNJ of 491 ㎍/ml) compared with flask fermentation.
Keywords
${\alpha}-Glucosidase$ inhibitor; 1-deoxynojirimycin; production; Bacillus subtilis MORI; response surface methodology;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Box GEP, Wilson KB. 1951. On the experimental attainment of optimum condition. J. Roy. Stat. Soc. B. 13: 1-45.
2 Kada S, Yabusaki M, Kaga T, Ashida H, Yoshida K. 2008. Identification of two major ammonia-releasing reactions involved in secondary fermentation. Biosci. Biotechnol. Biochem. 72: 1869-1876.   DOI
3 Kharel MK, Lee HC, Sohng JK, Liou K. 2002. Statistical optimization of medium components for the improved production of cystocin by Streptomyces sp. GCA0001. J. Ind. Eng. Chem. 8: 427-431.   DOI
4 Yatsunami K, Ichida M, Onodera S. 2008. The relationship between 1-deoxynojirimycin content and α-glucosidase inhibitory activity in leaves of 276 mulberry cultivars (Morus spp.) in Kyoto, Japan. J. Nat. Med. 62: 63-66.   DOI
5 Zhu YP, Yamaki K, Yoshihashi T, Kameyama MO, Li XT, Cheng YQ, et al. 2010. Purification and identification of 1-deoxynojirimycin (DNJ) in okara fermented by Bacillus subtilis B2 from Chinese traditional food (Meitaoza). J. Agric. Food Chem. 58: 4097-4103.   DOI
6 Pavlova K, Grigorova D. 1999. Production and properties of exopolysaccharide by Rhodotorula acheniorum MC. Food Res. Int. 32: 473-477.   DOI
7 DeFronzo RA. 2004. Pathogenesis of type 2 diabetes mellitus. Med. Clin. North Am. 88: 787-835.   DOI
8 Frandsen TP, Svensson B. 1998. Plant α-glucosidases of glycoside hydrolase family 31. Molecular properties, substrate specificity, reaction mechanism, and comparison with family members of different origin. Plant Mol. Biol. 37: 1-13.   DOI
9 Floris AV, Peter LL, Reinier PA, Eloy HV, Guy ER, Chris VW. 2005. α-Glucosidase inhibitors for patients with type 2 diabetes. Diabetic Care 28: 154-162.   DOI
10 Alain DB. 1998. Postprandial hyperglycaemia and α-glucosidase inhibitors. Diabetes Res. Clin. Pract. 40: 51-55.
11 Holman RR. 1998. Assessing the potential for α-glucosidase inhibitors in prediabetic states. Diabetes Res. Clin. Pract. 40: 21-25.   DOI
12 Patricia MH, Steven RH, Jennifer AW, Bryan WW. 2005. Effects of a medical food containing an herbal α-glucosidase on postprandial glycaemia and insulinemia in healthy adults. J. Am. Diet Assoc. 105: 65-71.
13 Kwon DY, Daily JW 3rd, Kim HJ, Park S. 2010. Antidiabetic effects of fermented soybean products on type 2 diabetes. Nutr. Res. 30: 1-13.   DOI
14 Clissold SP, Edwards C. 1998. Acarbose, a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 35: 214-243.   DOI
15 Toeller M. 1994. α-Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects. Eur. J. Clin. Invest. 24: 31-35.   DOI
16 Murai A, Iwamura K, Takada M, Ogawa K, Usui T, Okumura J. 2002. Control of postprandial hyperglycaemia by galactosyl maltobionolactone and its novel anti-amylase effect in mice. Life Sci. 71: 1405-1415.   DOI
17 Yoshikawa M, Morikawa T, Matsuda H, Tannbe G, Muraoka O. 2002. Absolute stereostructure of potent α-glucosidase inhibitor, salacinol, with unique thiosugar sulfonium sulfate inner salt structure from Salacia reticulata. Bioorg. Med. Chem. 10: 1547-1554.   DOI
18 Schmidt DD, Frommer W, Junge B, Muller L, Wingender W, Truscheit E, et al. 1977. α-glucosidase inhibitors, new complex oligosaccharides of microbial origin. Naturwissenschaften 64: 535-536.   DOI
19 Liu Y, Ma L, Chen WH, Wang B, Xu ZL. 2007. Synthesis of xanthone derivatives with extended π-sytems as α-glucosidase inhibitors: Insight into the probable binding mode. Bioorg. Med. Chem. 15: 2810-2814.   DOI
20 Iwasa R, Yamagami H, Shibata M. 1970. Studies on validamycins, new antibiotic I. Streptomyces hygroscopicus var. limoneus. validamycin producing organiam. J. Antibiotechnol. 23: 595-602.   DOI
21 Kimura T, Nakagawa K, Saito Y, Yamagishi K, Suzuki M, Yamaki K, et al. 2004. Simple and rapid determination of 1-deoxynojirimycin in mulberry leaves. Biofactors 22: 341-345.   DOI
22 Zhu YP, Fan JF, Cheng YQ, Li LT. 2008 Improvement of the antioxidant activity of Chinese traditional fermented okara (Meitauza) using Bacillus subtilis B2. Food Control 19: 654-661.   DOI
23 Zhu YP, Yin LJ, Cheng YQ, Yamaki K, Mori Y, Su YC, et al. 2008. Effects of sources of carbon and nitrogen on production of α-glucosidase inhibitor by a newly isolated of Bacillus subtilis B2. Food Chem. 109: 737-742.   DOI
24 Yagi M, Kono T, Aoyagi Y, Murai H. 1976. The structure of moraoline, a piperidine alkaloid from Morus species. Nippon Nougei kagaku kaishi 50: 571-572.   DOI
25 Stein DC, Kopec LK, Yasbin RE, Young FE. 1984. Characterization of Bacillus subtilis DSM704 and its production of 1-deoxynojirimycin. Appl. Environ. Microbiol. 8: 280-284.
26 Schmidt DD, Frommer W, Muller L, Truscheit E. 1979. Glucosidase inhibitiors from Bacilli. Naturwissenschaften. 66: 584-585.
27 Kameda Y, Asano N, Teranishi M, Natsui K. 1980. New cyclitols, degradation of validamycin A by Flavobacterium saccharophilum. J. Antibiot.(Tokyo) 33: 1573-1574.   DOI
28 Paek NS, Kang DJ, Choi YJ, Lee JJ, Kim TH, Kim KW. 1997. Production of 1-deoxynojirimycin by Streptomyces sp. SID9135. J. Microbiol. Biotechnol. 7: 262-266.
29 Ezure Y, Marue S, Miyazaki K, Kawamata M. 1985. Moranoline(1-deoxynojirimycin) fermentation and its improvement. Agric. Biol. Chem. 49: 1119-1125.   DOI
30 Chen HM, Yan XJ, Lin W, Zheng L, Zhang WW. 2004. A new method for screening alpha-glucosidase inhibitors and application to marine microorganisms. Pharm. Biol. 42: 416-421.   DOI
31 Haaland PD. 1989. Experimental design in biotechnology. New York: Dekker.
32 Lim JS, Park MC, Lee JH, Park SW, Kim SW. 2005. Optimization of culture medium and conditions for neofructooligosaccharides production by Penicillium citrinum. Eur. Food Res. Technol. 221: 639-644.   DOI
33 Kalil SJ, Maugeri F, Rodrigues MI. 2000. Response surface analysis and simulation as a tool for bioprocess design and optimization. Process Biochem. 35: 539-550.   DOI
34 Montgomery DC. 1991. Design and analysis of experiments. 3rd Ed. NY: Wiley.
35 Matsui T, Ueda T, Oki T, Sugita K, Terahara N, Matsumoto K. 2001. α-glucosidase inhibitory action of natural acylated anthocyanins. 1. Survey of natural pigments with potent inhibitory activity. J. Agric. Food Chem. 49: 1948-1951.   DOI
36 Kim JW, Kim SU, Lee HS, Kim I, Ahn MY, Ryu KS. 2003. Determination of 1-deoxynojirimycin in Morus alba L. leaves by derivatization with 9-fluorenylmethyl chloroformate followed by reversed-phase high-performance liquid chromatography. J. Chromatogr. A. 1002: 93-99.   DOI
37 Vichasilp C, Nakagawa K, Sookqong P, Suzuki Y, Kimura F, Higuchi O, et al. 2009. Optimization of 1-deoxynojirimycin extraction from mulberry leaves by using response surface methodology. Biosci. Biotechnol. Biochem. 73: 2684-2689.   DOI
38 Romaniouk AV, Silva A, Feng J, Vijay IK. 2004. Synthesis of a novel photoaffinity derivative of 1-deoxynojirimycin for active site-directed labeling of glucosidase I. Glycobiol. 14: 301-310.   DOI
39 Chen J, Cheng YQ, Yamaki K, Li LT. 2007. Anti-α-glucosidase activity of Chinese traditionally fermented soybean (douche). Food Chem. 103: 1091-1096.   DOI
40 Muraoka O, Yoshikai K, Takahashi H, Minematsu T, Lu G, Tanabe G, et al. 2006. Synthesis and biological evaluation of deoxy salacinols, the role of polar substituents in the side chain on the α-glucosidase inhibitory activity. Bioorg. Med. Chem. 14: 500-509.   DOI
41 Kim HS, Lee JY, Hwang KY, Cho YS, Park YS, Kang KD, et al. 2011. Isolation and identification of a Bacillus sp. producing α-glucosidase inhibitor 1-deoxynojirimycin. Korean J. Microbiol. Biotechnol. 39: 49-55.
42 Murao S, Miyata S. 1980. Isolation and characterization of a new trehalase inhibitor, S-GI. Agric. Biol. Chem. 44: 219-221.   DOI